Bupivacaine | Ropivacaine | |||||
All | PVB | TAP | All | PVB | TAP | |
24-hour breakthrough dosing | ||||||
Breakthrough mean (mg/kg) | 0.14 (0.03–1.3) n=385 | 0.14 (0.03–1.3) n=354 | 0.29 (0.25–0.45) n=31 | 0.27 (0.05–2.3), n=1109 | 0.43 (0.05–2.3), n=996 | 0.14 (0.06–0.3), n=113 |
Breakthrough max (mg/kg) | 0.29 (0.07–2.8) n=385 | 0.29 (0.07–2.8) n=354 | 0.29 (0.25–0.9) n=31 | 1.7 (0.12–7.2), n=1109 | 1.5 (0.1–7.2), n=996 | 3.1 (0.15–6.9), n=113 |
24-hour total doses (Bolus, infusion and breakthrough) | ||||||
Median 24-hour dose (mg/kg) | 6 (2.1–13.6) N=3223 | 6.1 (2.5–13.6) n=2700 | 4 (1.5–10) n=523 | 7.75 (2.1–15.7), n=3579 | 7.3 (2.1–15.9), n=3060 | 8.0 (2.2–15.1), n=519 |
IQR (mg/kg) | 4.1–9.6 | 5.0–9.6 | 3.2–6.8 | 6.1–11.1 | 5.8–11.1 | 7.7–12.4 |
Mean±SD (mg/kg) | 6.6±3.2 | 7.0±3.2 | 4.7±2.2 | 8.4±3.8 | 8.3±3.8 | 9.0±3.5 |
Unless otherwise specified, data presented as median (95% CI), n.
PVB, paravertebral; TAP, Transversus abdominis plane.